Genetic polymorphism of paraoxonase 1 (PON1) and susceptibility to Parkinson's disease
- 1 September 1998
- journal article
- Published by Elsevier in Brain Research
- Vol. 806 (2) , 271-273
- https://doi.org/10.1016/s0006-8993(98)00586-1
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Youth and Science
This publication has 13 references indexed in Scilit:
- Mutations in the parkin gene cause autosomal recessive juvenile parkinsonismNature, 1998
- Cigarette Smoke Extract Inhibits Plasma Paraoxonase Activity by Modification of the Enzyme's Free ThiolsBiochemical and Biophysical Research Communications, 1997
- Mutation in the α-Synuclein Gene Identified in Families with Parkinson's DiseaseScience, 1997
- The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarinNature Genetics, 1996
- A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease.Journal of Clinical Investigation, 1995
- Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetesThe Lancet, 1995
- Cigarette smoking and protection from Parkinson's diseaseNeurology, 1995
- The molecular basis of the human serum paraoxonase activity polymorphismNature Genetics, 1993
- Nicotinic Cholinergic Receptor Binding Sites in the Brain: Regulation in VivoScience, 1983
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983